×

Open WeChat and scan the QR code
Subscribe to our WeChat public account

HOME Overview Professional Fields Industry Fields Professionals Global Network News Publications Join Us Contact Us Subscribe CN EN JP
HOME > Publications > Newsletter > Regulation on Supervision and Administration of Medical Devices (2021 Revision)

Regulation on Supervision and Administration of Medical Devices (2021 Revision)

 2021-04-30751

ISSUING AUTHORITY:

State Council

DATE OF ISSUANCE:

February 9, 2021

EFFECTIVE DATE:

June 1, 2021

 

On February 9, 2021, the State Council promulgated the Regulation on the Supervision and Administration of Medical Devices (2021 Revision) (“Regulation”), which revised and adopted at the 119th executive meeting of the State Council on December 21, 2020, will take effect on June 1, 2021.

 

The quality and standards of medical devices have been improving amid the fast development of China's pharmaceutical industry in recent years. It is necessary to establish a more scientific and efficient evaluation and approval system for medical devices. The aim of this Regulation is to strengthen the responsibility of enterprises, clearly define the medical device recording and registration approval procedures, beefing up regulatory tools, additional regulations and supervision measures on medical device unique identification traceability and extension inspection.

 

The Regulation introduces a category-based administration of medical devices according to the level of risk. All products should satisfy the national compulsory standards for medical devices. Medical device registrants should strengthen quality lifecycle management and be responsible for safety and effectiveness during the research, production, and application process. The quality management systems should be built by medical device registrants and manufacturers to suit specific medical devices and to improve efficiency. They should strictly follow the required technical standards and ensure product quality to comply with the Regulation.

 

To further reduce the burden on enterprises and encourage innovation, the Regulation establishes a fast-track approval pathway for innovative medical devices, promotes the information construction of review and approval of medical device and optimizes the approval and filing procedures.

 

In terms of legal liability, the Regulation shows that severe punishment shall be meted out to companies and persons responsible for serious violations of the law, such as revocation of their licenses, prohibition of entry into trades and markets, and criminal responsibility shall be investigated in accordance with the law if any crime is involved.

 

Reference:

医疗器械监督管理条例